Anti-ADAM17 antibody (ab2051)

ab2051 has been referenced in 11 publications.

1. Thorp E et al. Shedding of the Mer Tyrosine Kinase Receptor Is Mediated by ADAM17 Protein through a Pathway Involving Reactive Oxygen Species, Protein Kinase C{delta}, and p38 Mitogen-activated Protein Kinase (MAPK). J Biol Chem 286:33335-44 (2011). PubMed: 21828049
2. Spin JM et al. Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm. Physiol Genomics 43:993-1003 (2011). IHC. PubMed: 21712436
3. Shirakabe K et al. VIP36 Protein Is a Target of Ectodomain Shedding and Regulates Phagocytosis in Macrophage Raw 264.7 Cells. J Biol Chem 286:43154-63 (2011). WB; Mouse. PubMed: 22016386
4. Rabquer BJ et al. Junctional Adhesion Molecule-C Is a Soluble Mediator of Angiogenesis. J Immunol : (2010). WB; Human. PubMed: 20592283
5. Lu Y et al. Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells. Eur J Pharmacol 641:102-7 (2010). WB; Human. PubMed: 20553913
6. Gijsen M et al. HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer. PLoS Biol 8:e1000563 (2010). WB; Human. PubMed: 21203579
7. Hanson EM et al. Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells. J Immunol 183:937-44 (2009). Flow Cyt. PubMed: 19553533
8. Katakowski M et al. Tumorigenicity of cortical astrocyte cell line induced by the protease ADAM17. Cancer Sci 100:1597-604 (2009). WB; Mouse. PubMed: 19515085
9. Zheng X et al. Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness. Cancer Sci 98:674-84 (2007). PubMed: 17355261
10. Hakulinen J & Keski-Oja J ADAM10-mediated release of complement membrane cofactor protein during apoptosis of epithelial cells. J Biol Chem 281:21369-76 (2006). PubMed: 16735514
11. Plumb J et al. ADAM-17 and TIMP3 protein and mRNA expression in spinal cord white matter of rats with acute experimental autoimmune encephalomyelitis. J Neuroimmunol 164:1-9 (2005). PubMed: 15878627